MAGEA9 and neoplasm: For example, the frequency of MAGE-A2- and MAGE-A9-specific T cells ranged from 0.026% to 0.128%, whereas that of MAGE-A3.2 ranged from 0.058% to 3.82%, which was the highest ASTC frequency obtained with tumor peptides.